Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan; Division of Health Science, Graduate School of Medicine, Osaka University, Suita, Japan.
Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Cancer Epidemiol. 2022 Oct;80:102218. doi: 10.1016/j.canep.2022.102218. Epub 2022 Jul 20.
Some cancer survivors develop second primary cancers. However, differences in prognosis between patients who have and have not had prior cancer have not been established. We examined and compared the prognoses of such patients.
Using the record-linked database of the population-based Cancer Registry of Osaka Prefecture and Vital Statistics in Japan, we identified patients aged ≥ 40 years who were diagnosed with stomach (n = 70,946), colorectal (n = 60,582), or lung (n = 58,016) cancers during 1995-2009. We defined these cancers as index cancers. Patients were classified into three groups according to history of prior cancer and interval between diagnosis of index and prior cancer: single (no prior cancer or interval of ≥10 years), synchronous (interval ≤3 months), and metachronous (interval 3 months to 10 years). The 5-year prognosis from index cancer diagnosis was investigated using the Kaplan-Meier method and log-rank test.
5-year prognoses of patients with synchronous stomach and colorectal cancers were significantly worse than that of patients with single primary, about 60 % of these patients' deaths being attributable to the prior cancer. In contrast, 5-year prognoses of patients with metachronous primaries were not significantly worse, except for men with colorectal cancer. The percentages of index cancer deaths were 1.7-4.3 times those for non-index cancer deaths.
A prior cancer contributed to an inferior prognosis in patients with synchronous stomach and colorectal cancers. The prognoses of patients with metachronous primaries were more affected by the index than by the prior cancer, whereas most of them had similar or better prognoses than did patients with a single primary. This finding would help to relieve cancer survivors' anxiety about their development and prognosis of metachronous second primary cancer.
一些癌症幸存者会发展出第二原发癌。然而,患有和不患有先前癌症的患者之间的预后差异尚未确定。我们检查并比较了这些患者的预后。
我们使用日本大阪府癌症登记处和人口动态统计记录链接数据库,确定了 1995-2009 年间年龄≥40 岁的诊断为胃癌(n=70946)、结直肠癌(n=60582)或肺癌(n=58016)的患者。我们将这些癌症定义为索引癌症。根据先前癌症的病史和诊断索引与先前癌症之间的间隔,患者被分为三组:单一(无先前癌症或间隔≥10 年)、同步(间隔≤3 个月)和异时(间隔 3 个月至 10 年)。使用 Kaplan-Meier 方法和对数秩检验调查从索引癌症诊断的 5 年预后。
同步胃和结直肠癌患者的 5 年预后明显差于单发性患者,这些患者约 60%的死亡归因于先前的癌症。相比之下,除了男性结直肠癌患者外,异时性原发性患者的 5 年预后并无显著恶化。指数癌症死亡的百分比是非指数癌症死亡的 1.7-4.3 倍。
先前的癌症导致同步胃和结直肠癌患者的预后较差。异时性原发性患者的预后受指数癌症的影响大于先前癌症的影响,而大多数患者的预后与单发性患者相似或更好。这一发现有助于减轻癌症幸存者对发展和异时性第二原发癌预后的焦虑。